Neurology: vascular parkinsonism, other disorders with signs of chronic cerebrovascular insufficiency, disturbances of memory, attention, and speech, dizziness. Diseases of the nervous system with poor intellectual-mnestic performance and dysfunction of the emotional-conative sphere. 
Psychiatry: neurotic and asthenodynamic depressive conditions with predominant signs of adynamia, asthenia, cenesto-hypochondriacal disorders, ideational retardation, torpid apathetic defective conditions, schizophrenia, psycho-organic syndromes of various origin, senile and atrophic processes, combined therapy of mental disorders. Combined therapy of senile dementia, including Alzheimer’s disease. Pediatrics:cerebrostenic and encephalopathic disorders, disturbances of memory, intellectual insufficiency. In patients withchronic alcoholism the medication is used to diminish the signs of asthenia, intellectual-mnestic and other disorders of mental performance.Combined therapy of myocardial infarction and neuroinfection.

It is recommended to be used in cases when the imbalance of intestinal microflora is possible: at the time of using antibiotics, stress, a change of diet, violation of the mode and deterioration of nutrition quality and different conditions of the organism (such as: allergy, irritable bowel syndrome, etc.), which is indirectly associated with an imbalance of intestinal microflora.

It is recommended to be used in cases when the imbalance of intestinal microflora is possible: at the time of using antibiotics, stress, a change of diet, violation of the mode and deterioration of nutrition quality and different conditions of the organism (such as: allergy, irritable bowel syndrome, etc.), which is indirectly associated with an imbalance of intestinal microflora.

Psoriasis, atopic dermatitis, seborrheic dermatitis in adults and children over than 1 year old, particularly when large forms, as well as itching, irritation, inflammation and increased skin dryness.

Infections caused by microorganisms sensitive to the drug: respiratory tract infections including pneumonia, bronchitis; infections of skin and subcutaneous tissue; intra-abdominal infections, including peritonitis and biliary tract infections; gynecological infections; septicemia. Empiric therapy for febrile neutropenic patients. Prevention of postoperative complications in intra-abdominal surgery. Pneumonia; urinary tract infections, including pyelonephritis; infections of skin and subcutaneous tissue; septicemia; empiric therapy for febrile neutropenic patients; bacterial meningitis.

As a single agent or as a part of combined therapy of dental diseases (stomatitis, gingivitis, glossitis, periodontitis), upper respiratory tract diseases (pharyngitis, tonsillitis, including post-tonsillectomy condition, laryngitis, and pharyngo- and laryngotracheitis, chronic bronchitis); in gastroenterology (gastric and duodenal ulcers, acute and chronic gastritis, duodenitis, colitis and enterocolitis of various origin), in proctology (proctitis, proctosigmoiditis, hemorrhoids, skin itching in the anal and perianal areas), in gynecology (cervical erosion, colpitis, cervicitis, laceration of the perineum and vagina occurring during delivery).

Adding to standard treatment with the use of beta-blocker with the purpose of decline of risk of the morbidity and death rate, related to the cardiovascular diseases, for stable patients with disfunction of the left ventricle (faction of the troop landing of the left ventricle ≤40%) and the clinical signs of heart failure after the recently carried heart attack of myocardium.
Adding to standard optimal therapy with the purpose of decline of risk of morbidity and death rate related to the cardiovascular diseases, for adult patients with the heart failure of II of class (chronic) on classification of NYHA and disfunction of the left ventricle (faction of the troop landing of the left ventricle ≤30%).